Related Experiment Video
Updated: Mar 30, 2026
06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
5.7K
Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery
David R Hall1, Dima Kozakov2, Adrian Whitty3
1Acpharis Inc., 160 North Mill Street, Holliston, MA 01746, USA.
Trends in Pharmacological Sciences
|November 6, 2015
Summary
Analyzing protein binding sites reveals how hot spots guide fragment-based drug discovery (FBDD). Understanding hot spot strength and arrangement is key to advancing fragment hits into effective drug candidates.
Area of Science:
- Structural biology
- Computational chemistry
- Drug discovery
Background:
- Fragment-based drug discovery (FBDD) relies on identifying and optimizing initial fragment hits.
- Protein binding sites contain 'hot spots' that significantly contribute to ligand binding energy.
- Assessing hot spot characteristics is crucial for predicting FBDD success.
Purpose of the Study:
- To quantitatively understand how protein 3D structures define binding hot spots.
- To elucidate the relationship between hot spot properties and ligand binding potential.
- To guide the effective application of FBDD in drug development.
Main Methods:
- Analysis of published protein-ligand binding data.
- Computational assessment of hot spot energy contributions.
- Structure-based evaluation of hot spot characteristics (strength, number, spatial arrangement).
Main Results:
- Published data are sufficient for a sophisticated, quantitative understanding of hot spots.
- Hot spot strength, number, and arrangement dictate binding potential for various ligand sizes.
- The top-ranking hot spot's strength and fragment complementarity are critical factors.
Conclusions:
- Improved understanding of hot spots enhances FBDD strategy.
- This knowledge aids in selecting and advancing fragment hits for drug development.
- Protein structure analysis provides essential insights for successful FBDD.
Related Concept Videos
01:26Drug Discovery: Overview
13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
01:49Conserved Binding Sites
5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K